BWM
BNTX icon

Birchcreek Wealth Management’s BioNTech BNTX Stock Holding History

Birchcreek Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,527
Closed -$229K – 130
2022
Q4 		$229K Sell
1,527
-70
-4% -$10.8K 0.2% 116
2022
Q3 		$215K Sell
1,597
-150
-9% -$22.9K 0.2% 111
2022
Q2 		$260K Buy
1,747
+25
+1% +$3.82K 0.23% 95
2022
Q1 		$294K Buy
1,722
+275
+19% +$46.2K 0.26% 85
2021
Q4 		$373K Buy
1,447
+240
+20% +$65.7K 0.33% 70
2021
Q3 		$329K Sell
1,207
-296
-20% -$94.1K 0.31% 71
2021
Q2 		$336K Buy
+1,503
New +$283K 0.32% 71
2021
Q1 		– Sell
-1,557
Closed -$126K – 135
2020
Q4 		$126K Buy
+1,557
New +$153K 0.12% 129

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Birchcreek Wealth Management's BNTX Position: Q1 2023 in Review

Birchcreek Wealth Management sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 1,527 shares — an estimated $229K sold.

Birchcreek Wealth Management first reported a position in BNTX in Q4 2020 and held it in 8 quarters. The position peaked at $373K in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Birchcreek Wealth Management reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Birchcreek Wealth Management sold 1,527 BioNTech shares in Q1 2023, an estimated $229K.
  • Birchcreek Wealth Management first reported a position in BioNTech in Q4 2020 and held it in 8 quarters.
  • Birchcreek Wealth Management's BioNTech position peaked at $373K in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Birchcreek Wealth Management's 13F filing for Q1 2023, filed 2 May 2023.